— Shares of Dollar Tree popped more than 3% after the discount retailer reiterated its fiscal second-quarter 2023 earnings guidance. The company expected quarterly earnings between 79 cents per share and 89 cents per share. It also maintained its full-year outlook for the fiscal year.
— The Netherlands-based gene therapy stock dropped 38.7% after the company gave an update on a late-stage trial for a potential therapy for Huntington's Disease. On Tuesday, the company said it hit a $100 million milestone related to its first commercial sale of Hemgenix, which is used in the treatment of adults with hemophilia B.
مصر أحدث الأخبار, مصر عناوين
Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.
Dollar Tree targeting $10+ per-share earnings in fiscal 2026Dollar Tree Inc. set goals for the next few years in a statement released ahead of an analyst day, and said it’s targeting $10+ per-share earnings in fiscal...
اقرأ أكثر »
Stocks fall, U.S. dollar up as investors assess U.S. rate outlookChina cut its key lending benchmarks as authorities seek to shore up a slowing economic recovery, although concerns about the property market meant the easing was not as large as expected, disappointing markets and sending stocks lower
اقرأ أكثر »
Stocks making the biggest premarket moves: Alibaba, Dice Therapeutics, Avis and moreThese are the stocks posting the largest moves in the premarket.
اقرأ أكثر »